Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)

BACKGROUND: 1. Compare SBRT +/− ADT for oligorecurrent-castration-sensitive PCa (OCS-PCa) in terms of efficacy, toxicity and Quality of Life (QoL). 2. Develop biology/imaging based prognostic tool that allows identifying OCS-PCa subclasses. METHODS: 1. Randomized clinical study (3 years for accrual...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Marvaso, Giulia, Ciardo, Delia, Corrao, Giulia, Gandini, Sara, Fodor, Cristiana, Zerini, Dario, Rojas, Damaris Patricia, Augugliaro, Matteo, Bonizzi, Giuseppina, Pece, Salvatore, Cattani, Federica, Mazzocco, Ketti, Mistretta, Francesco Alessandro, Musi, Gennaro, Alessi, Sarah, Petralia, Giuseppe, Pravettoni, Gabriella, De Cobelli, Ottavio, Di Fiore, Pier Paolo, Viale, Giuseppe, Orecchia, Roberto, Jereczek-Fossa, Barbara Alicja
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734417/
https://ncbi.nlm.nih.gov/pubmed/31500605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6117-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars